Eton Pharmaceuticals, Inc. ETON Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Eton Pharmaceuticals, Inc. (ETON) reported operating lease right-of-use assets in other assets of $301K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Eton Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets increased by 90.5% year-over-year, from $158K to $301K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets has grown at a 9.7% compound annual growth rate (CAGR), from $195K to $310K.